BTG gains pre-natal test technology
This article was originally published in Clinica
Executive Summary
BTG, a commercialisation company based in the UK, has acquired European and US rights to DNA foetal diagnosis products via maternal serum or plasma, According to BTG, tests developed from the intellectual property can be applied to a number of inherited disorders.